Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. Pemberton

OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) in Previously-Treated Malignant Mesothelioma (MM): Final Analysis

Journal of Thoracic Oncology

English

Related publications

NGR-hTNF in Previously Treated Patients With Malignant Pleural Mesothelioma (MPM) .

Journal of Clinical Oncology

English

Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial

Hematological Oncology

English

P2.06-09 MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination With Pembrolizumab in PTS With Malignant Mesothelioma

Journal of Thoracic Oncology

English

KEYNOTE-045: Randomized Phase 3 Trial of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Previously Treated Metastatic Urothelial Cancer.

Journal of Clinical Oncology

English

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2012

English

Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509

Journal of Thoracic Oncology

English

MA12.06 STELLAR – Final Results of a Phase 2 Trial of TTFields With Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma

Journal of Thoracic Oncology

English

A Phase II Trial of Ixabepilone in Asian Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine-Based Chemotherapy

Cancer Chemotherapy and Pharmacology

English

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia

Clinical Cancer Research

Cancer Research

Oncology

2012

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. Pemberton

OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) in Previously-Treated Malignant Mesothelioma (MM): Final Analysis

Related publications

NGR-hTNF in Previously Treated Patients With Malignant Pleural Mesothelioma (MPM) .

Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial

P2.06-09 MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination With Pembrolizumab in PTS With Malignant Mesothelioma

KEYNOTE-045: Randomized Phase 3 Trial of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Previously Treated Metastatic Urothelial Cancer.

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509

MA12.06 STELLAR – Final Results of a Phase 2 Trial of TTFields With Chemotherapy for First-Line Treatment of Malignant Pleural Mesothelioma

A Phase II Trial of Ixabepilone in Asian Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine-Based Chemotherapy

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenstrom Macroglobulinemia